GIGA Science and Perception Research Group CHU Liège
Liège, 4000, Belgium
NCT Number: NCT06885294
Impact of physical therapy with hypnosis on the functional capacity of the upper limb in stroked patients.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Liège, 4000, Belgium
The cerebrovascular accident (CVA) is a pathology generating many disabled people. Physiotherapy is one of the usual rehabilitation techniques for a patient with sequelae of ischemia or cerebral hemorrhage. Combined with another therapeutic approach, hypnosis, it could increase the patient's motor performance.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Stroke patients will be randomly assigned to join one of the three groups. The first group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. After another month without any treatment, they will undergo a third and final assessment. All evaluations will last approximately 1 hour.
Stroke patients will be randomly assigned to join one of the three groups. The second group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. Patients will continue their standard physiotherapy care during these 4 weeks. After another month without any treatment, they will undergo a third and final assessment. All evaluations will last approximately 1 hour.
The control group will be assessed initially and then after 4 weeks. After the second assessment, they will receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. All evaluation sessions will last approximately 1 hour.
Time frame: 8 weeks
Measurement of shoulder (flexion, extension, abduction, internal rotation, external rotation), elbow (flexion, extension), wrist (flexion, extension)
Time frame: 8 weeks
Measurement of muscle activation on Ashworth scale (extension and flexion of shoulder, elbow, wrist, fingers, thumb) => 0%-100% (a higher score means a worse outcome)
Time frame: 8 weeks
Stroke Upper Limb Capacity Scale (SULCS) => 0%-100% (a higher score means a better outcome)
Time frame: 8 weeks
Functional Independence Measure (FIM) from complete dependence to independence => 0%-100% (a higher score means a better outcome)
Time frame: 8 weeks
Measurement of pathological upper limb strength on MRC scale by group/time/joint/movement => 0%-100% (a higher score means a better outcome)
Time frame: 8 weeks
Measurement of manual dexterity and motor skills by moving blocks into box comparing healthy upper limb with pathological upper limb => 0%-100% (a higher score means a better outcome)
Time frame: 8 weeks
Measurement of degree of disability => 0%-100% (a higher score means a worse outcome)
University of Liege
Other
Impact of Physiotherapy Combined to Hypnosis on Superior Limb Functional Capacities of AVC Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07411664
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Kaposvár, Somogy County, Hungary
View Trial DetailsNCT07719387
Brain Diseases, Cardiovascular Diseases
Stony Brook, New York, United States
View Trial DetailsNCT07681102
Brain Diseases, Cardiovascular Diseases
Berkeley, California, United States
View Trial DetailsNCT04534556
Brain Diseases, Cardiovascular Diseases
Dallas, Texas, United States
View Trial Details